* Any views expressed in this article are those of the author and not of Thomson Reuters Foundation.
First there were national shortages of HIV medication, then of HIV tests, now Swaziland lacks the lab tests essential for initiating and managing HIV patients on treatment. To make matters worse, the country chose not to apply for the international funding that could have safeguarded antiretroviral (ARV) stocks.